Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology
Reexamination Certificate
2008-12-29
2010-11-30
Bunner, Bridget E (Department: 1647)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Method of regulating cell metabolism or physiology
C435S004000, C530S350000, C530S399000
Reexamination Certificate
active
07842502
ABSTRACT:
The present invention disclosed the expression of CXCL6 by cells which are able to form stable cartilage. The invention describes the use of these cells and of CXCL6 to promote cartilage (and underlying bone) formation e.g. in the repair of cartilage or osteochondral defects. The invention further describes the use of chemokines in the modulation of progenitor cell differentiation.
REFERENCES:
patent: 5786217 (1998-07-01), Tubo et al.
patent: 5840524 (1998-11-01), Van Damme et al.
patent: 6090625 (2000-07-01), Abuljadayfl et al.
patent: 6410268 (2002-06-01), Ni et al.
patent: 6413511 (2002-07-01), Glorioso et al.
patent: 2002/0123483 (2002-09-01), Saxena et al.
patent: 2003/0224345 (2003-12-01), West et al.
patent: 2005/0019865 (2005-01-01), Kihm et al.
patent: 2006/0153817 (2006-07-01), Kihm et al.
patent: 2006/0154366 (2006-07-01), Brown et al.
patent: 2006/0154367 (2006-07-01), Kihm et al.
patent: 1 312 614 (2003-05-01), None
patent: 2 177 996 (2002-01-01), None
Sell, S. (ed.) Stem Cells Handbook. 2004. New Jersey: Human Press, pp. 1-18 and table of contents.
Phillips, A.. The challenge of gene therapy and DNA delivery. J Pharm Pharmacology 53:1169-1174, 2001.
Rubanyi et al. The future of human gene therapy. Mol Aspects Med 22: 113-142, 2001.
Juengst, E.T. What next for human gene therapy? Brit Med J 326: 1410-1411, 2003.
Lin et al. The Chondrocyte: biology and clinical application. Tissue Engineering 12(7): 1971-1984, 2006.
Haringman et al., “Chemokines in Joint Disease: The Key to Inflammation?”Ann Rheum. Dis. 63(10):1186-1194 (2004).
Imhof et al., “Subchondral Bone and Cartilage Disease: A Rediscovered Functional Unit,”Invest. Radiol. 35(10):581-588 (2000).
Lindahl et al., “Cartilage Repair with Chondrocytes: Clinical and Cellular Aspects” inTissue Engineering of Cartilage and Bone, Novartis Foundation Symposium 249 UK: John Wiley and Sons Ltd., pp. 175-189 (2003).
Meyer and Wiesmann,Bone and Cartilage, Germany: Springer, pp. 7-46 (2006).
Wuyts et al., “Characterization of Synthetic Human Granulocyte Chemotactic Protein 2: Usage of Chemokine Receptors CXCR1 and CXCR2 and In Vivo Inflammatory Properties,”Biochem. 36(9):2716-2723 (1997).
Wuyts et al., “The CXC Chemokine GCP-2/CXCL6 is Predominantly Induced in Mesenchymal Cells by Interleukin-1β and is Down-Regulated by Interfernon-γ: Comparison with Interleukin-8/CXCL8,”Lab. Invest. 83(1):23-34 (2003).
International Preliminary Report on Patentability for PCT/BE2004/000117, mailed Dec. 5, 2005.
International Search Report for PCT/BE2004/000117, mailed Feb. 2, 2005.
Response to the Written Opinion for PCT/BE2004/000117, mailed Jun. 1, 2005.
Translation of Office Action mailed Jul. 9, 2008 in connection with Russian Patent Application No. 2006107536/(008178).
Written Opinion of the International Searching Authority for PCT/BE2004/000117, mailed Feb. 2, 2005.
Office Action for Japanese Application No. 2006-522851, dated Jun. 8, 2010.
English language summary dated Jun. 10, 2010 of Office Action for Japanese Application No. 2006-522851, dated Jun. 8, 2010 (2 pages). (Redacted).
De Bari Cosimo
Dell'Accio Francesco
Luyten Frank
Bunner Bridget E
Clark & Elbing LLP
Tigenix N.V.
LandOfFree
Use of CXCL6 chemokine for inducing precursor cells into... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of CXCL6 chemokine for inducing precursor cells into..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of CXCL6 chemokine for inducing precursor cells into... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4248676